This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
CRA recently spoke to Vice President Gregory Vistnes about how his agency background has informed his current work in merger and non-merger cases both before the agencies and in private litigation.
But this change has led to complex relationships among pharmaceutical manufacturers, hospitals, pharmacies, and third-party administrators, increasing...
The issue is especially timely given provisions in the EU’s Digital Markets Act (DMA) designed to expand access to data held by large digital platforms. The...
CRA is a proud sponsor of the event bringing together EU & UK merger control experts to address recent cases, regulatory developments, diverging...
CRA is a proud sponsor of the event bringing together over 180 industry leaders for an unmissable day of cutting-edge insights, forward-looking analysis, and...
